Socorro Miranda-Hernandez

Dr Socorro Miranda-Hernandez serves as a Postdoctoral Research Fellow at the Australian Institute of Tropical Health and Medicine, James Cook University (JCU). She holds a PhD in Biochemistry from JCU and a bachelor's degree in veterinary medicine from the Autonomous University of the State of Mexico.

Dr Miranda-Hernandez's research focuses on elucidating immunogenetic mechanisms underlying disease and conducting preclinical testing of innovative therapies and vaccines for human health applications. She employs a suite of spatial technologies, ranging from fundamental histopathological methods to advanced spatial tissue profiling techniques such as multiplex immunohistochemistry and image-based spatial molecular technology. She has extensive experience in biosafety containments levels 1 to 3 facilities and has developed her research in congenic, transgenic and knockout murine models of human diseases. She is driven by a commitment to translating scientific discovery into practical solutions to benefit communities, industry and policymakers.

Her intellectual contributions are reflected in publications in respected journals, and her achievements have been recognised with several awards from esteemed organisations including the Australian and New Zealand Society for Immunology, the Federation of Immunological Societies of Asia-Oceania, Host-Pathogen Interactions and Disease, JCU and the Autonomous University of the State of Mexico. Dr Miranda-Hernandez's research has also been supported by external grants, notably from the National Institutes of Health and the Validate network, which is supported by major international health and research funding bodies.

Over the past five years, she has played an integral role in projects investigating the immunogenetic mechanisms involved in the containment and reactivation of Latent Tuberculosis in immunocompromised hosts, conducting preclinical trials of novel vaccines for Tuberculosis, and exploring host-directed therapies to enhance control of that disease. Her work is characterised by a strong commitment to innovation and collaboration, aiming to make a meaningful impact on human health.